Vycor Medical, Inc. (OTCMKTS:VYCO – Get Free Report) was the target of a significant decline in short interest in May. As of May 29th, there was short interest totaling 7,489 shares, a decline of 34.2% from the May 14th total of 11,389 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 13,377 shares, the short-interest ratio is presently 0.6 days.
Vycor Medical Price Performance
Shares of OTCMKTS:VYCO opened at $0.07 on Tuesday. The firm’s 50-day simple moving average is $0.07 and its 200-day simple moving average is $0.11. Vycor Medical has a fifty-two week low of $0.03 and a fifty-two week high of $0.20.
Vycor Medical Company Profile
Vycor Medical, Inc is a medical device company specializing in the design, development and manufacture of minimally invasive cranial access systems for use in neurosurgery. The company’s proprietary endoport platform is engineered to provide neurosurgeons with controlled, cannula-based access for intracranial procedures such as tumor biopsy, resection and hematoma drainage. By integrating visualization channels and atraumatic retraction technology, Vycor’s products are intended to reduce collateral damage to healthy brain tissue and streamline procedural workflows.
The company’s core portfolio includes its flagship endoport system along with complementary accessories such as obturators, sheaths and closure devices.
Read More
- Five stocks we like better than Vycor Medical
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Vycor Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vycor Medical and related companies with MarketBeat.com's FREE daily email newsletter.
